Indications and uses
for the treatment of acne.
for the treatment of acne.
cover the entire affected area with a thin layer and rinse thoroughly one to three times daily because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor if bothersome dryness or peeling occurs, reduce application to once a day or every other day
Salicylic Acid 2.0%
Acne Treatment
for the treatment of acne.
For external use only
• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs only use one topical acne medication at a time. • avoid contact with eyes. If contact occurs, flush thoroughly with water.
If swallowed, get medical help or contact a Poison Control Center immediately.
water, sodium C14-16 olefin sulfonate, glycerin, cocamidopropyl betaine, acrylates copolymer, cocamidopropyl PG-dimonium chloride phosphate, polyquaternium-7, citrus grandis (grapefruit) fruit extract, anthemis nobilis flower extract (roman chamomile), camellia sinensis leaf extract (green tea), chondrus crispus powder (carrageenan), agar, neopentyl glycol dicaprylate/dicaparate, sodium ascorbyl phosphate (vitamin C phosphate), propylene glycol, C12-15 alkyl lactate, polysorbate 20, butylene glycol, polyvinyl alcohol, potassium chloride, phenethyl alcohol, PPG-2 methyl ether, disodium EDTA, sodium chloride, sodium hydroxide, benzlkonium chloride, sodium benzotriazolyl butylphenol sulfonate, fragrance, mica, titanium dioxid, iron oxides, red 30, red 40, ext. violet 2
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63940-082 | 63940-082-55 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2502fe09-c28b-e6c5-e063-6394a90a3508 | d55381c7-e614-28cc-e053-2995a90a7e3b | 2024-10-21 | Warnings | d55381c7-e614-28cc-e053-2995a90a7e3b |
Adverse event summaries are temporarily unavailable. Other product information remains available.